Literature DB >> 21075709

Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006.

Chia-Ying Liu1, Chun-Hsing Liao, Yee-Chun Chen, Shan-Chwen Chang.   

Abstract

BACKGROUND/
PURPOSE: Healthcare-associated infections, formerly known as nosocomial infections, are one of the most important issues in current practice. Understanding trends in overall infection rates, as well as their incidence and proportion among different causative organisms, can help us to better define our infection control methods and therapy goals. To understand the changing epidemiology of nosocomial bloodstream infections (BSI) in Taiwan, we retrospectively collected nosocomial infection data from 11 hospitals and examined the trends and changing patterns of nosocomial BSI.
METHODS: Eleven major teaching hospitals in Taiwan were invited to participate in the study. The overall density of nosocomial infections and major BSI-causing organisms, including Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, and Candida species, were collected. The distribution of the different Candida species was also recorded. Background parameters from the 11 hospitals, including the size of the hospital, hospital capacity, the number of blood stream infection events, and average length of stay, were also recorded.
RESULTS: The incidence of nosocomial BSI ranged 0.23-2.56 per 1,000 patient-days, which accounted for 8-43% of all nosocomial infections. The most common causative organism of nosocomial bacteremia was S. aureus, ranging 0.88-0.01 per 1,000 patient-days. Overall, the incidence of S. aureus bacteremia has decreased over the last 13 years, but this difference was not statistically significant (p = 0.053). The rate of Candida fungemia (p < 0.01) and A. baumannii (p = 0.03) bacteremia increased significantly. C. albicans accounted for most cases of nosocomial fungemia, ranging from 40% to 80%, followed by Candida tropicalis, Candida parapsilosis and Candida glabrata. However, the incidence varied significantly from hospital to hospital, and the highest incidence was observed in a cancer center.
CONCLUSION: The overall incidence rate of S. aureus bacteremia in the 11 major hospitals studied had decreased over the last decade, though the difference was not statistically significant. However, the rate of Candida fungemia and A. baumannii bacteremia had increased significantly.
Copyright © 2010 Taiwan Society of Microbiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21075709     DOI: 10.1016/S1684-1182(10)60065-5

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  12 in total

1.  Effect of the use of low and high potency statins and sepsis outcomes.

Authors:  Shu-Yu Ou; Hsi Chu; Pei-Wen Chao; Shuo-Ming Ou; Yi-Jung Lee; Shu-Chen Kuo; Szu-Yuan Li; Chia-Jen Shih; Yung-Tai Chen
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

2.  Species identification of invasive yeasts including Candida in Pakistan: limitations of phenotypic methods.

Authors:  Joveria Farooqi; Kauser Jabeen; Noureen Saeed; Afia Zafar; Mary Eleanor Brandt; Rumina Hasan
Journal:  J Pak Med Assoc       Date:  2012-10       Impact factor: 0.781

3.  Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.

Authors:  J Q Farooqi; K Jabeen; N Saeed; N Iqbal; B Malik; S R Lockhart; A Zafar; M E Brandt; R Hasan
Journal:  J Med Microbiol       Date:  2012-10-25       Impact factor: 2.472

4.  Changing aetiology of healthcare-associated bloodstream infections at three medical centres in Taiwan, 2000-2011.

Authors:  C C Lai; Y H Chen; S H Lin; K P Chung; W H Sheng; W C Ko; P R Hsueh
Journal:  Epidemiol Infect       Date:  2014-10       Impact factor: 4.434

5.  Of mice, flies--and men? Comparing fungal infection models for large-scale screening efforts.

Authors:  Sascha Brunke; Jessica Quintin; Lydia Kasper; Ilse D Jacobsen; Martin E Richter; Ekkehard Hiller; Tobias Schwarzmüller; Christophe d'Enfert; Karl Kuchler; Steffen Rupp; Bernhard Hube; Dominique Ferrandon
Journal:  Dis Model Mech       Date:  2015-03-18       Impact factor: 5.758

6.  Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies.

Authors:  Zena Salih; Jim Cavet; Mike Dennis; Tim Somervaille; Adrian Bloor; Samar Kulkarni
Journal:  South Asian J Cancer       Date:  2013-10

7.  The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study.

Authors:  Chung-Jong Kim; Hong-Bin Kim; Myoung-don Oh; Yunhee Kim; Arim Kim; Sung-Hee Oh; Kyoung-Ho Song; Eu Kim; Yong Cho; Young Choi; Jinyong Park; Baek-Nam Kim; Nam-Joong Kim; Kye-Hyung Kim; Eun Lee; Jae-Bum Jun; Young Kim; Sung Kiem; Hee Choi; Eun Choo; Kyung-Mok Sohn; Shinwon Lee; Hyun Chang; Ji Bang; Su Lee; Jae Lee; Seong Park; Min Jeon; Na Yun
Journal:  BMC Infect Dis       Date:  2014-11-14       Impact factor: 3.090

8.  Surveillance on secular trends of incidence and mortality for device-associated infection in the intensive care unit setting at a tertiary medical center in Taiwan, 2000-2008: a retrospective observational study.

Authors:  Yin-Yin Chen; Liang-Yu Chen; Seng-Yi Lin; Pesus Chou; Shu-Yuan Liao; Fu-Der Wang
Journal:  BMC Infect Dis       Date:  2012-09-10       Impact factor: 3.090

9.  The use of Chitosan to enhance photodynamic inactivation against Candida albicans and its drug-resistant clinical isolates.

Authors:  Hsiung-Fei Chien; Chueh-Pin Chen; Yee-Chun Chen; Po-Han Chang; Tsuimin Tsai; Chin-Tin Chen
Journal:  Int J Mol Sci       Date:  2013-04-03       Impact factor: 5.923

10.  Epidemiology of candidemia in Latin America: a laboratory-based survey.

Authors:  Marcio Nucci; Flavio Queiroz-Telles; Tito Alvarado-Matute; Iris Nora Tiraboschi; Jorge Cortes; Jeannete Zurita; Manuel Guzman-Blanco; Maria Elena Santolaya; Luis Thompson; Jose Sifuentes-Osornio; Juan I Echevarria; Arnaldo L Colombo
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.